MMSI
Merit Medical Systems Inc
85.00$
-2.5%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 32.4% | 47.7% | 47.5% | 49.0% | 45.3% | 38.2% | 38.8% | 35.7% | 37.5% | 38.7% | 40.5% | 38.8% | |
| 3.4% | 25.2% | 25.1% | 26.9% | 22.0% | 15.6% | 16.0% | 13.3% | 14.9% | 16.7% | 17.9% | 15.7% | |
| 3.4% | 25.3% | 25.1% | 26.9% | 22.0% | 15.6% | 16.0% | 13.3% | 14.9% | 16.7% | 17.9% | 15.7% | |
| 10.6% | 8.1% | 8.3% | 8.3% | 9.0% | 8.6% | 8.8% | 8.7% | 8.8% | 8.3% | 8.3% | 8.8% | |
| 16.8% | 13.1% | 13.0% | 12.6% | 13.1% | 12.7% | 12.9% | 12.5% | 12.4% | 12.4% | 13.0% | 13.1% | |
| 21.1% | 16.4% | 16.4% | 16.1% | 16.8% | 19.2% | 18.8% | 19.5% | 19.3% | 18.9% | 18.5% | 18.8% | |
| 18.8% | 14.0% | 13.6% | 12.8% | 15.6% | 20.6% | 19.4% | 21.7% | 20.5% | 20.0% | 18.8% | 21.4% | |
| 32.0% | 48.3% | 46.7% | 45.9% | 44.3% | 43.0% | 42.1% | 42.5% | 41.9% | 41.0% | 40.2% | 41.3% | |
| 10.3% | 8.8% | 7.9% | 7.9% | 8.5% | 8.9% | 8.0% | 8.7% | 8.8% | 8.9% | 8.0% | 9.3% | |
| 0.9% | 0.5% | 0.5% | 0.5% | 0.5% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | 0.4% | |
| 2.7% | 2.8% | 2.1% | 2.3% | 2.6% | 2.8% | 2.6% | 2.7% | 2.5% | 2.3% | 2.5% | 2.5% | |
| 15.6% | 35.4% | 34.4% | 33.8% | 31.6% | 30.2% | 29.6% | 28.3% | 27.9% | 27.3% | 27.0% | 25.7% | |
| 68.0% | 51.7% | 53.3% | 54.1% | 55.7% | 57.0% | 57.9% | 57.5% | 58.1% | 59.0% | 59.8% | 58.7% | |
| 30.3% | 24.7% | 25.9% | 26.9% | 28.1% | 28.8% | 29.4% | 29.3% | 29.9% | 30.7% | 31.8% | 31.6% | |
| 3.2% | 2.5% | 2.5% | 2.5% | 2.5% | 2.5% | 2.5% | 2.3% | 2.3% | 2.2% | 2.2% | 2.1% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.